Cell therapy in tendon disorders: what is the current evidence?
systematic_review · Level I
Where this comes from
- Record sourced from PubMed, PMID 20699425.
- Also identified by DOI 10.1177/0363546510373574.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Various types of tissue-derived cells are being experimented with for the treatment of tendinopathy, tendon repair, and use in tissue engineering. The aim of this systematic review is to explore the current evidence with a view to evaluate the potential of this therapeutic intervention. Systematic review. A review of the literature was conducted using PubMed. Search criteria included keywords "tendinopathy," "tendinitis," "tendinosis," "epicondylitis," "stem cell," and "cell therapy." Articles not written in English language were excluded. A total number of 379 articles were identified and a critical appraisal of the relevant articles was undertaken, which encompassed human and animal research. The review included articles related to various tissue-derived cells such as tendon progenitors, adipose tissue, synovium, muscle, bone marrow, and skin. The utility of cell therapy in tissue engineering and rotator cuff repair was also assessed. With the limitation of the available evidence, the literature suggests that cell therapy is applicable and may be effective for the treatment of tendinopathy. However, further research into the precise biological mechanisms, long-term implications, and cost-effectiveness is needed.
Medical subject headings
- Cell- and Tissue-Based Therapy
- Evidence-Based Medicine
- Stem Cell Transplantation
- Tendon Injuries